Emergence of a Novel SARS-CoV-2 Variant in Southern California

Nextstrain: real-time tracking of pathogen evolution

Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154

GISAID: Global initiative on sharing all influenza data – from vision to reality

Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.012 · Cited by 1,420

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.003 · Cited by 1,178

Genetic Variants of SARS-CoV-2—What Do They Mean?

Lauring, A. S., & Hodcroft, E. B. (2021) · JAMA · doi:10.1001/jama.2020.27124 · Cited by 604

Emergence of a new SARS-CoV-2 variant in the UK

Tang, J. W.-T., Tambyah, P. A., & Hui, D. S. C. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.12.024 · Cited by 273

Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic

Zhang, W., Govindavari, J. P., Davis, B. D., Chen, S. S., Kim, J. T., Song, J., Lopategui, J. R., Plummer, J., & Vail, E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.24191 · Cited by 36

S gene dropout patterns in SARS-CoV-2 tests suggest spread of the H69del/V70del mutation in the USPreprint

Washington, N. L., White, S. J., Barrett, K. M. S., Cirulli, E. T., Bolze, A., & Lu, J. T. (2020) · medRxiv · doi:10.1101/2020.12.24.20248814 · Cited by 35

A Prospective Study to Evaluate the Clinical Performance of A Novel MultitargetBased Antigen Test on the Detection of SARS-CoV-2 in Symptomatic PopulationComparison to Nuclear Acid-Based Tests

Wang, Y., Rao, E., Wan, D. D., Patterson, C., Wan, D. D., Pogosyan, A., Wan, J., & Rao, J. (2021) · Journal of Epidemiology and Public Health Reviews · doi:10.16966/2471-8211.211

A Critique of Recent Medical Research in JAMA on COVID-19

McAleer, M. (2021) · Advances in Decision Sciences · doi:10.47654/v25y2021i1p40-142 · Cited by 1

The New Variants of Corona-Virus Mutations: An Understanding to Their Infectivity, Immunological Tolerance and Vaccine Efficacy

Garg, P. (2021) · Nano LIFE · doi:10.1142/s1793984421300107 · Cited by 2

Robust Representation and Efficient Feature Selection Allows for Effective Clustering of SARS-CoV-2 Variants

Tayebi, Z., Ali, S., & Patterson, M. (2021) · Algorithms · doi:10.3390/a14120348 · Cited by 27

The lineage of coronavirus SARS-CoV-2 of Russian origin: Genetic characteristics and correlations with clinical parameters and severity of coronavirus infection

Glotov, O. S., Chernov, A. N., Korobeynikov, A., Kalinin, R. S., Tsai, V. V., Anisenkova, A. Y., Петрович, У. С., Lapidus, A. L., Mosenko, S. V., & Shcherbak, S. G. (2022) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2021-36-4-132-143 · Cited by 1

Can we Succeed in the Fight Against SARS-CoV-2 with its Emerging New Variants?

Tavakol, S., Tavakol, H., Alavijeh, M. S., & Seifalian, A. M. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220506142117 · Cited by 1

COVID-19 mRNA Vaccines

Yau, Y., Mishra, S., Easterling, M., & Kumar, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-9001-3_31 · Cited by 1

LE VIRUS SARS-COV-2 ET SES VARIANTS

MONETTI, M., Pozzetto, B., PLOTTON, C., & GOCKO, X. (2021) · EXERCER · doi:10.56746/exercer.2021.171.118 · Cited by 1

SARS-CoV-2 genome sequencing with Oxford Nanopore Technology and Rapid PCR Barcoding in BoliviaPreprint

Rollano-Peñaloza, O. M., Barrera, C. D., & Michel, A. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.06.451357 · Cited by 1

Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control TrialPreprint

Li, J., Wu, S., Guo, X., Tang, R., Huang, B., Chen, X., Huang, H.-T., Chen, Y., Hou, L., Gou, J.-B., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4000565 · Cited by 1

WITHDRAWNPreprint

Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-l393t-v35 · Cited by 1

WITHDRAWNPreprint

Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v30 · Cited by 1

WITHDRAWNPreprint

Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-l393t-v33 · Cited by 1

COVID‐19: Virology

Najafi, S., Tofighi, S., & Sobczyk, J. (2022) · Wiley eBooks · doi:10.1002/9781119789741.ch2 · Cited by 1

Factores relacionados a la mortalidad en pacientes con COVID – 19 hospitalizados en la unidad de cuidados intensivos Hospital Nacional Carlos Seguin Escobedo Arequipa junio a diciembre del 2020

Meza, G. (2022) · Universidad Privada San Juan Bautista · doi:10.59590/upsjb/fcs.med.hum/tesis/3906 · Cited by 1

Human microbiota is a reservoir of SARS-CoV-2 advantageous mutationsPreprint

Cao, B., Wang, X., Yin, W., Gao, Z., & Xia, B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567485 · Cited by 1

An Update on the Leading COVID-19 Vaccines

Eladely, A. (2021) · The University of Louisville Journal of Respiratory Infections · doi:10.18297/jri/vol5/iss1/2

WITHDRAWNPreprint

Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v32

Detection of two CAL.20C SARS-CoV-2 variants in Monterrey metropolitan area in Northeast MexicoPreprint

Galán-Huerta, K. A., Rivas-Estilla, A. M., Lozano-Sepúlveda, S. A., Martínez-Acuña, N., Arellanos-Soto, D., Montes‐de‐Oca‐Luna, R., Treviño‐Garza, C., de la O-Cavazos, M. E., & Ramos‐Jiménez, J. (2021) · medRxiv · doi:10.1101/2021.04.05.21251104

Leveraging a Public-Private-Academic Collaborative Partnership to confront challenges in the COVID-19 pandemic.

Denvir, J. (2021) · Marshall Journal of Medicine · doi:10.33470/2379-9536.1335

The INDIA Mutations and B.1.617 Variant: Is There a Global "Strategy" for Mutations and Evolution of Variants of The SARS-CoV2 Genome?Preprint

Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0689.v1

Visualizing Amino Acid Substitutions in a Physicochemical Vector SpacePreprint

Nemzer, L. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.15.452549

Network analysis outlines strengths and weaknesses of emerging SARS-CoV-2 Spike variantsPreprint

Manrique, P. D., Chakraborty, S., Nguyen, K., Mansbach, R. A., Korber, B., & Gnanakaran, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.03.458946

Delta variant - A new phase of COVID-19 in India

Sreenivas, S. S. (2021) · International Journal of Medical Science · doi:10.14445/23939117/ijms-v8i7p105

SARS-CoV-2 variant transmission in a community-health population (Mexico City, Mexico)Preprint

Zhang, W., Martinez, M., Davis, B. D., Chen, S. S., Martínez, J., Corona, C., Díaz, G. D. R. L., Makhoul, E. P., Heneidi, S. G., Goldberg, J., et al. (2021) · medRxiv · doi:10.1101/2021.10.18.21264783

Aptamers for Detection and Diagnostics (ADD): Can mobile systems linked to biosensors support molecular diagnostics of SARS-CoV-2? Should molecular medicine explore multiple alternatives as adjuvants to or replacement for traditional and non-traditional vaccines?Preprint

Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v35

BARREIRA HEMATOENCEFÁLICA, EIXO GASTROINTESTINAL-SNC E INFECÇÃO PELO SARS-COV2

Arnholdt, A. C. V. (2021) · doi:10.22533/at.ed.30721041111

A PESSOA COM DEFICIÊNCIA VISUAL NO CONTEXTO DA PANDEMIA DO COVID-19

Figueiredo, E. L. A., Brandolin, F., Oliveira, I. J. D. A. S., Figueiredo, J. R. M., de Oliveira, J. T. M., & Abade, M. L. (2021) · doi:10.22533/at.ed.30721041115

AVANÇO DA IMUNIZAÇÃO CONTRA SARS-CoV-2 E O IMPACTO NO CONTROLE DA DISSEMINAÇÃO DAS NOVAS VARIANTES

Santos, L. D. O. (2021) · doi:10.22533/at.ed.30721041116

PRÁXIS DA FISIOTERAPIA NA SINDEMIA POR COVID-19: CONTEXTUALIZAÇÃO E PROGNOSE

Pereira, C. M. D. S., Oliveira, I. J. D. A. S., de Oliveira, J. T. M., Fraga, M. C., de Lima, R. P., Ribeiro, S. D. S., & de Souza, M. F. (2021) · doi:10.22533/at.ed.30721041114

FATORES GENÉTICOS E EPIGENÉTICOS RELACIONADOS À COVID-19

Colete, C. C. F. A., Martins, L. M., & Mangiavacchi, P. M. (2021) · doi:10.22533/at.ed.3072104112

INTERSECÇÕES EM CENÁRIO PANDÊMICO: LINHAS QUE SE INTERCRUZAM NO ACIRRAMENTO DAS DESIGUALDADES EM TEMPOS DE COVID-19

Curcio, F. S., da Costa, H. M. V., Rangel, T. L. V., Mangiavacchi, B. M., & Dellatorre, R. D. S. Z. (2021) · doi:10.22533/at.ed.3072104119

ÉTICA EM PESQUISA E INTEGRIDADE CIENTÍFICA NA PANDEMIA SARS-COV-2 (COVID-19): QUESTÕES E PERSPECTIVAS SOBRE A ATUAÇÃO DOS COMITÊS DE ÉTICA EM PESQUISA

Nunes, C. D. R., Curcio, F. S., & Borges, T. R. B. (2021) · doi:10.22533/at.ed.3072104115

UM DIÁLOGO ENTRE TÊMIS E HIGÉIA: PENSAR OS OBSTÁCULOS EMERGENTES NA PROMOÇÃO DO DIREITO À SAÚDE EM TEMPOS DE PANDEMIA DA COVID-19 NO CENÁRIO BRASILEIRO

Rangel, T. L. V., Curcio, F. S., & da Costa, H. M. V. (2021) · doi:10.22533/at.ed.3072104114

[Anthralin erythema: effect of concentration, contact time, oxidation products and corticosteroids. Clinical, reflection photometry and electron microscopy studies].

Puschmann, M. (1983) · PubMed

SARS-CoV-2 Therapeutic Landscape, Opportunity and Future Threats

Sharma, O. P., Seiz, W., & Scheele, J. (2021) · The Open COVID Journal · doi:10.2174/2666958702101010205

The INDIA Mutations and B.1.617 Variant: Is There a Global "Strategy" for Mutations and Evolution of Variants of The SARS-CoV2 Genome?Preprint

Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0689.v2

WITHDRAWNPreprint

Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v31

Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?Preprint

Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v33

Study of COVID Pandemic in Selected High Burden Countries in the World

Rachakonda, R., Shaik, A. W., & Shaik, U. P. (2021) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2021/813

An expanded high throughput RT-PCR assay to rapidly identify all known SARS-CoV-2 variants of concern using melting temperature codingPreprint

Banada, P. P., Green, R., Banik, S., Streck, D. L., Montalvan, I., Reiss, R., Jones, R., Marras, S. A. E., Chakravorty, S., & Alland, D. (2022) · medRxiv · doi:10.1101/2022.01.18.22269424

ChAdOx1 nCoV-19, BNT162b2 and CoronaVac Vaccines Do Not Induce as Strong Neutralising Antibodies with Broad Variant Protection as Infection and Suggest Vaccines that Induce Broader Sterilising Immunity are Essential to Stop the PandemicPreprint

Chua, J. X., Durrant, L. G., Chok, Y. L., & Lai, O. M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4062765

Most Concern Strains of Coronavirus-2 and Diagnostic Protocol in Iraqi’s Hospitals: A review

Musafer, H. K., Abdulrazaq, R. A., AL-Bayati, M. A., Kaabi, S. A. G., & Abdulateef, B. (2022) · Mağallaẗ ʻulūm al-rāfidayn · doi:10.33899/rjs.2022.172934

Vaccination and Covid 19 Infections

Mihaltan, F. D., & Constantin, A. (2022) · Internal Medicine · doi:10.2478/inmed-2022-0201

Aptamers for Detection and Diagnostics (ADD): Can mobile systems linked to biosensors support molecular diagnostics of SARS-CoV-2? Should molecular medicine explore multiple alternatives as adjuvants to or replacement for traditional and non-traditional vaccines?Preprint

Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v36

WITHDRAWNPreprint

Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v28

WITHDRAWNPreprint

Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v29

WITHDRAWNPreprint

Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-l393t-v34

SARS-CoV2 Variants and Vaccines mRNA Spikes Fibonacci Numerical UA/CG MetastructuresPreprint

Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0034.v3

Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?Preprint

Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v34

Viral Dynamic Surveillance in COVID‐19 Patients: A Cohort Study

Bi, D., Chen, Z., Wei, S., Xie, Z., Zang, N., Mo, L., Liu, Z., Wang, Y., Cao, L., Zhao, F., et al. (2022) · BioMed Research International · doi:10.1155/2022/1399268

Coronavirus disease 2019

El-Sharkawy, S., Abbas, N. F., & AbdEl-Aal, W. E. (2022) · Journal of The Arab Society for Medical Research · doi:10.4103/jasmr.jasmr_13_22

Effect of Covid-19 and Role of AI Approaches in the Context of India

Kushwaha, S., Thakur, V., & Tamrkar, L. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s01.234

Vaccination schemes and CoronaVac: Are there differences between adults and older adults hospitalized by COVID-19?

Cárdenas, C., Rojas, L., Valenzuela, J. M., García, Y. I. P., Silva, M. T., & Kappes, M. S. (2023) · Revista Chilena de Anestesia · doi:10.25237/revchilanestv52n5-11

Conceptual Modeling for Bioinformatics

Bernasconi, A., & Alberto García, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95502-7.00003-8

Extracellular and intracellular antiviral effects of ultraviolet A against severe acute respiratory syndrome coronavirus-2 are variant-independent

Leite, G., Mehravar, S., Pimentel, M., Mathur, R., MELMED, G. Y., Teagle, V., Barlow, G. M., & Rezaie, A. R. (2024) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2024.104097

Computational tools and databases at the forefront to study geographic and genomic distribution of SARS-CoV-2 variants

Ali, A., Malla, B. A., Ganie, S., Rehman, M. U., & Ahmad, S. B. (2024) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-024-00462-5

Data-Driven Methods for Viral Variants’ Identification

Bernasconi, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95502-7.00087-7

The evaluation of SARS-CoV-2 mutations at the early stage of the pandemic in Istanbul population

Uyar, Y., Komurcu, S. Z. M., Artik, Y., Cesur, N. P., Tanrıverdi, A., & Şanlı, K. (2024) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-024-00750-y · Cited by 1

Evolution and monitoring of SARS-COV-2 genetic mutations in Ecuador

Guacho, C. V. C., Martínez, N. G., & Vizuete, E. G. V. (2024) · Salud Ciencia y Tecnología - Serie de Conferencias · doi:10.56294/sctconf2024.109

Advancements in Structural Basis of Covalent Inhibitors Targeting SARS-CoV-2 Essential Proteins

Fatima, I., Alshabrmi, F. M., Alkhayl, F. F. A., Qasim, M., Shafqat, A., Batool, S., Jawad, M. T., Qamar, M. T. U., & Rehman, A. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673323348241208080419

EPIC: Enhancing Privacy Through Iterative Collaboration

Chourasia, P., Lonkar, H., Ali, S., & Patterson, M. (2025) · Communications in computer and information science · doi:10.1007/978-3-031-91428-7_2

Evolution of split-protein technologies in virology: From mechanistic discovery and diagnostics to therapeutic promise

Zhou, K., Lei, Y., Zhou, Y., & Zhan, J. (2025) · Journal of Virus Eradication · doi:10.1016/j.jve.2025.100610

Additional file 2 of Lineage abundance estimation for SARS-CoV-2 in wastewater using transcriptome quantification techniques

Baaijens, J. A., Zulli, A., Ott, I. M., Nika, I., van der Lugt, M. J., Petrone, M. E., Alpert, T., Fauver, J. R., Kalinich, C. C., Vogels, C. B. F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21524237

Additional file 1 of Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor

Liu, J., Bodnar, B. H., Meng, F., Khan, A. I., Wang, X., Saribas, S., Wang, T., Lohani, S. C., Wang, P., Wei, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16544166

Additional file 1 of Lineage abundance estimation for SARS-CoV-2 in wastewater using transcriptome quantification techniques

Baaijens, J. A., Zulli, A., Ott, I. M., Nika, I., van der Lugt, M. J., Petrone, M. E., Alpert, T., Fauver, J. R., Kalinich, C. C., Vogels, C. B. F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21524234

Additional file 2 of Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor

Liu, J., Bodnar, B. H., Meng, F., Khan, A. I., Wang, X., Saribas, S., Wang, T., Lohani, S. C., Wang, P., Wei, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16544169

SARS-CoV-2 intra-host recombination promotes epistatic spike interactions and temperature-dependent adaptation

Altaf, M., Cheng, M. T. K., González-Vázquez, L. D., Jesu Castin, E., Kemp, S. A., Hisner, R., Martin, D. P., Thukral, L., Meng, B., & Gupta, R. K. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117460 · Cited by 1

A tale of SARS-CoV-2 genomic surveillance in Mali: Variants introductions and transmission dynamics

Keita, N. Y., Onywera, H., Abdou, M., Dicko, Z., Diarra, F. M., Kamena, O., Diarra, A., Koné, K. M., Dicko, A. A., Koita, D., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0352020

Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants

Tchesnokova, V. L., Kulasekara, H. D., Larson, L., Bowers, V., Rechkina, E., Kisiela, D., Sledneva, Y., Choudhury, D., Maslova, I., Deng, K., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00921-21 · Cited by 214

Genomic epidemiology of the Los Angeles COVID-19 outbreak and the early history of the B.1.43 strain in the USA

Guo, L., Boocock, J., Hilt, E. E., Chandrasekaran, S., Zhang, Y., Munugala, C., Sathe, L., Alexander, N., Arboleda, V. A., Jonathan Flint, C., et al. (2022) · BMC Genomics · doi:10.1186/s12864-022-08488-7 · Cited by 2

Genomic Epidemiology of the Los Angeles COVID-19 OutbreakPreprint

Guo, L., Boocock, J., Hilt, E. E., Chandrasekaran, S., Zhang, Y., Munugala, C., Sathe, L., Alexander, N., Arboleda, V. A., Jonathan Flint, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-423686/v1 · Cited by 1

Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants

Wang, R., Chen, J., Gao, K., Hozumi, Y., Yin, C., & Wei, G. (2021) · Communications Biology · doi:10.1038/s42003-021-01754-6 · Cited by 201

Emergence and Evolution of a Prevalent New SARS-CoV-2 Variant in the United StatesPreprint

Pater, A. A., Bosmeny, M. S., Barkau, C. L., Ovington, K. N., Chilamkurthy, R., Parasrampuria, M., Eddington, S. B., Yinusa, A. O., White, A. A., Metz, P. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.11.426287 · Cited by 37